JOHNSON & JOHNSON Executive Compensation

Named executive officer pay as disclosed in the company’s jnj-20260309.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.

$32,758,111

J. Duato, Chief Executive Officer — total compensation

$1,600,000

base salary

Healthcare

industry

Executive	Title	Base salary	Total compensation
J. Duato	Chairman/CEO	$1,600,000	$32,758,111
J. Wolk	EVP, CFO	$1,240,646	$14,405,442
J. Taubert	EVP, WWC Innovative Medicine	$1,220,308	$14,030,063
J. Reed	EVP, Innovative Medicine, R&D	$1,220,308	$12,214,062
T. Schmid	EVP, WWC, MedTech	$942,308	$9,336,765

Source: JOHNSON & JOHNSON Definitive Proxy Statement (DEF 14A), filed jnj-20260309.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.